Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-012833
Filing Date
2020-11-05
Accepted
2020-11-05 16:03:20
Documents
95
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lci-20200930x10q.htm   iXBRL 10-Q 1691155
2 EX-31.1 lci-20200930xex31d1.htm EX-31.1 10356
3 EX-31.2 lci-20200930xex31d2.htm EX-31.2 10421
4 EX-32 lci-20200930xex32.htm EX-32 7989
  Complete submission text file 0001558370-20-012833.txt   8909195

Data Files

Seq Description Document Type Size
5 EX-101.SCH lci-20200930.xsd EX-101.SCH 59576
6 EX-101.CAL lci-20200930_cal.xml EX-101.CAL 79514
7 EX-101.DEF lci-20200930_def.xml EX-101.DEF 218053
8 EX-101.LAB lci-20200930_lab.xml EX-101.LAB 624874
9 EX-101.PRE lci-20200930_pre.xml EX-101.PRE 467061
10 EXTRACTED XBRL INSTANCE DOCUMENT lci-20200930x10q_htm.xml XML 1767146
Mailing Address 9000 STATE ROAD 9000 STATE ROAD PHLADELPHIA PA 19136
Business Address 9000 STATE RD PHILADELPHIA PA 19136 2153339000
LANNETT CO INC (Filer) CIK: 0000057725 (see all company filings)

EIN.: 230787699 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31298 | Film No.: 201290358
SIC: 2834 Pharmaceutical Preparations